BDSX logo

BDSX
Biodesix Inc

1,667
Mkt Cap
$129.44M
Volume
5,620.00
52W High
$20.21
52W Low
$3.44
PE Ratio
-2.77
BDSX Fundamentals
Price
$13.08
Prev Close
$13.13
Open
$13.12
50D MA
$14.08
Beta
0.50
Avg. Volume
124,474.32
EPS (Annual)
-$4.67
P/B
-43.96
Rev/Employee
$264,967.07
$105.11
Loading...
Loading...
News
all
press releases
Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study
PLSE begins patient enrollment in NANOPULSE-AF pivotal study, advancing its NPS tech toward potential AF treatment approval and entry into a large cardiac market.
Zacks·2h ago
News Placeholder
More News
News Placeholder
Aberdeen Group plc Takes $1.78 Million Position in Biodesix, Inc. $BDSX
Aberdeen Group plc purchased a new stake in shares of Biodesix, Inc. (NASDAQ:BDSX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission...
MarketBeat·3d ago
News Placeholder
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
DVA rides on EPS growth and early IKC profitability, but flat treatment volumes and reimbursement risks raise questions about sustaining momentum.
Zacks·4d ago
News Placeholder
Brookdale Senior Q1'26 Sneak Peek: Occupancy Volume Rises to 82.1%
BKD's Q1'26 occupancy climbs to 82.1%, marking a fourth straight quarter of year-over-year gains despite a slight dip from Q4'25.
Zacks·4d ago
News Placeholder
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
CAH's specialty growth, strong pharma demand and expanding services portfolio are driving earnings momentum and positioning it for sustained long-term growth.
Zacks·5d ago
News Placeholder
GRAIL Partners With Epic to Broaden Galleri Test Access Across US
GRAIL partners with Epic to embed its Galleri cancer test into EHRs, expanding access across nearly 450 health systems and streamlining clinical workflows nationwide.
Zacks·5d ago
News Placeholder
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery
STXS jumps on FDA clearance of Synchrony system, a 4K platform integrating cath lab tech with cloud connectivity to boost workflow, precision and digital surgery.
Zacks·6d ago
News Placeholder
Revvity Gains on Diagnostics Strength, Faces China Headwinds
RVTY gains from strong diagnostics and software growth, but China weakness, soft demand, and margin pressures temper its near-term outlook.
Zacks·7d ago
News Placeholder
Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year?
Here is how Aura Biosciences, Inc. (AURA) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.
Zacks·7d ago
News Placeholder
Allworth Financial LP Reduces Holdings in Biodesix, Inc. $BDSX
Allworth Financial LP reduced its stake in shares of Biodesix, Inc. (NASDAQ:BDSX - Free Report) by 95.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·12d ago
<
1
2
...
>

Latest BDSX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.